QRVO vs TARS · P/E 27, rev $3.68B vs rev $336.0M
Qorvo Inc (QRVO) versus Tarsus Pharmaceuticals Inc (TARS) — a side-by-side from cached financials, not a winner call.
Qorvo Inc (QRVO) is a semiconductors company listed on NASDAQ.
Tarsus Pharmaceuticals Inc (TARS) is a biotechnology company listed on NASDAQ.
Latest reported QRVO revenue for 2026-03-28 was $3.68B. Net income was $339.0M. Revenue was down 1.1% from 2025-03-29 to 2026-03-28. QRVO currently screens at market cap $8.54B and trailing P/E 26.8.
Latest reported TARS revenue for 2026-06-30 was $336.0M. Net income was -$25.5M. TARS currently screens at market cap $2.66B.
QRVO currently screens at market cap $8.54B and trailing P/E 26.8. TARS currently screens at market cap $2.66B.
Not investment advice. Open the QRVO and TARS stock pages for the full models.
Not investment advice.